CSM Advisors LLC Sells 11,185 Shares of Agilent Technologies, Inc. $A

CSM Advisors LLC reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 52.2% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 10,247 shares of the medical research company’s stock after selling 11,185 shares during the quarter. CSM Advisors LLC’s holdings in Agilent Technologies were worth $1,315,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of A. Brighton Jones LLC boosted its stake in Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after acquiring an additional 270 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after purchasing an additional 769 shares during the period. Geneos Wealth Management Inc. increased its stake in Agilent Technologies by 54.8% in the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after purchasing an additional 212 shares in the last quarter. Acadian Asset Management LLC raised its holdings in Agilent Technologies by 16.5% in the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after purchasing an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new stake in Agilent Technologies in the second quarter worth $273,000.

Agilent Technologies Trading Up 0.3%

NYSE A opened at $111.88 on Tuesday. The stock has a market capitalization of $31.62 billion, a price-to-earnings ratio of 24.70, a PEG ratio of 2.35 and a beta of 1.31. The stock’s 50 day moving average price is $129.72 and its two-hundred day moving average price is $135.85. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The firm had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company’s revenue was up 7.0% compared to the same quarter last year. During the same period last year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s dividend payout ratio is presently 22.52%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their price target for the company from $155.00 to $160.00 in a report on Monday, January 5th. JPMorgan Chase & Co. boosted their price objective on Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Bank of America increased their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 25th. The Goldman Sachs Group began coverage on shares of Agilent Technologies in a report on Tuesday, December 9th. They set a “buy” rating and a $170.00 target price on the stock. Finally, Robert W. Baird lifted their price target on shares of Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research note on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $161.20.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.